Diagnostic Medical Systems S.A. (ALDMS.PA)
EUR 0.68
(-2.57%)
EUR 0.68
(-2.57%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 15.84 Million EUR | 14.52% |
| 2022 | 13.83 Million EUR | -0.37% |
| 2021 | 13.88 Million EUR | 9.87% |
| 2020 | 12.63 Million EUR | 46.92% |
| 2019 | 8.6 Million EUR | 28.37% |
| 2018 | 6.7 Million EUR | -31.66% |
| 2017 | 9.8 Million EUR | -41.64% |
| 2016 | 16.8 Million EUR | 11.09% |
| 2015 | 15.12 Million EUR | 56.19% |
| 2014 | 9.68 Million EUR | 19.44% |
| 2013 | 8.1 Million EUR | 6.22% |
| 2012 | 7.63 Million EUR | 213.34% |
| 2011 | 2.43 Million EUR | -55.77% |
| 2010 | 5.5 Million EUR | 34.9% |
| 2009 | 4.08 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -535 Thousand EUR | 0.0% |
| 2023 Q4 | -1.28 Million EUR | 0.0% |
| 2023 Q2 | 886 Thousand EUR | 20209.46% |
| 2023 FY | 15.84 Million EUR | 14.52% |
| 2023 Q1 | 4362.50 EUR | -98.72% |
| 2022 Q4 | 342 Thousand EUR | 0.0% |
| 2022 FY | 13.83 Million EUR | -0.37% |
| 2022 Q2 | -511 Thousand EUR | -113.28% |
| 2022 Q1 | 3.84 Million EUR | 550.47% |
| 2021 FY | 13.88 Million EUR | 9.87% |
| 2021 Q1 | 3.75 Million EUR | 254.53% |
| 2021 Q2 | -916 Thousand EUR | -124.4% |
| 2021 Q4 | -854 Thousand EUR | 0.0% |
| 2020 Q1 | 3.35 Million EUR | 212.6% |
| 2020 Q3 | 3.4 Million EUR | 290.69% |
| 2020 Q2 | -1.78 Million EUR | -153.21% |
| 2020 Q4 | -2.42 Million EUR | -171.44% |
| 2020 FY | 12.63 Million EUR | 46.92% |
| 2019 FY | 8.6 Million EUR | 28.37% |
| 2019 Q4 | -2.97 Million EUR | -196.56% |
| 2019 Q3 | 3.08 Million EUR | 10.33% |
| 2019 Q1 | 2.79 Million EUR | 18.44% |
| 2019 Q2 | 2.79 Million EUR | 0.0% |
| 2018 Q1 | 2.63 Million EUR | -10.23% |
| 2018 FY | 6.7 Million EUR | -31.66% |
| 2018 Q4 | 2.35 Million EUR | 0.0% |
| 2018 Q3 | 2.35 Million EUR | -10.39% |
| 2018 Q2 | 2.63 Million EUR | 0.0% |
| 2017 FY | 9.8 Million EUR | -41.64% |
| 2017 Q3 | 2.93 Million EUR | 15.05% |
| 2017 Q4 | 2.93 Million EUR | 0.0% |
| 2017 Q1 | 2.54 Million EUR | -45.88% |
| 2017 Q2 | 2.54 Million EUR | 0.0% |
| 2016 FY | 16.8 Million EUR | 11.09% |
| 2016 Q3 | 4.7 Million EUR | 6.3% |
| 2016 Q4 | 4.7 Million EUR | 0.0% |
| 2016 Q1 | 4.43 Million EUR | -7.25% |
| 2016 Q2 | 4.43 Million EUR | 0.0% |
| 2015 Q2 | 3.28 Million EUR | 0.0% |
| 2015 Q4 | 4.77 Million EUR | 0.0% |
| 2015 Q3 | 4.77 Million EUR | 45.23% |
| 2015 Q1 | 3.28 Million EUR | -0.65% |
| 2015 FY | 15.12 Million EUR | 56.19% |
| 2014 Q4 | 3.31 Million EUR | 0.0% |
| 2014 FY | 9.68 Million EUR | 19.44% |
| 2014 Q3 | 3.31 Million EUR | 88.53% |
| 2014 Q1 | 1.75 Million EUR | -31.41% |
| 2014 Q2 | 1.75 Million EUR | 0.0% |
| 2013 Q2 | 1.67 Million EUR | 0.0% |
| 2013 Q1 | 1.67 Million EUR | 0.0% |
| 2013 FY | 8.1 Million EUR | 6.22% |
| 2013 Q4 | 2.56 Million EUR | 0.0% |
| 2013 Q3 | 2.56 Million EUR | 53.02% |
| 2012 FY | 7.63 Million EUR | 213.34% |
| 2011 FY | 2.43 Million EUR | -55.77% |
| 2010 FY | 5.5 Million EUR | 34.9% |
| 2009 FY | 4.08 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Affluent Medical SA | -1.2 Million EUR | 1420.25% |
| Bluelinea Société Anonyme | -3.84 Million EUR | 511.765% |
| Carmat SA | -30.97 Million EUR | 151.154% |
| Euromedis Groupe | 3.57 Million EUR | -343.586% |
| Eurobio Scientific Société anonyme | 53.96 Million EUR | 70.643% |
| Ikonisys S.A. | 255.82 Thousand EUR | -6092.857% |
| Implanet S.A. | 3.13 Million EUR | -405.843% |
| Median Technologies SA | -2.55 Million EUR | 721.051% |
| SpineGuard SA | 3.37 Million EUR | -368.859% |
| Theraclion SA | -1.08 Million EUR | 1566.422% |
| Euroapi S.A. | 164.6 Million EUR | 90.375% |
| Guerbet SA | 197.14 Million EUR | 91.964% |
| Ion Beam Applications SA | 134.44 Million EUR | 88.216% |
| Koninklijke Philips N.V. | 7.44 Billion EUR | 99.787% |
| Sequana Medical NV | 548.04 Thousand EUR | -2790.8% |